CGON.NASDAQCg Oncology, INC

4/A: Decheng Capital Corrects Form 4 Filing, Discloses Omitted CG Oncology Stock Purchase

Sentiment:

SEC Filing (Form 4/A Amendment)


Decheng Capital amends its previous SEC filing to include a purchase of 400,000 shares of CG Oncology common stock at $19 per share on January 29, 2024.

Summary

  • Decheng Capital Global Life Sciences Fund IV, L.P. filed an amended Form 4 with the SEC on April 9, 2024.
  • The amendment corrects an omission in the original filing from January 31, 2024.
  • The corrected filing discloses the purchase of 400,000 shares of CG Oncology, Inc. (CGON) common stock on January 29, 2024, at a price of $19 per share.
  • Following the transaction, Decheng Capital Global Life Sciences Fund IV, L.P. beneficially owns 4,958,810 shares of CG Oncology common stock.
  • The filing also includes information about the relationships of Decheng Capital Management IV (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC and Xiangmin Cui to Decheng Capital Global Life Sciences Fund IV, L.P. and CG Oncology.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it is a correction of a previous filing. It doesn't necessarily indicate a positive or negative outlook for the company, but rather ensures accurate reporting.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and significant shareholders, providing transparency to the market.

Key Dates

DateDescription
01/29/2024Date of transaction: Purchase of 400,000 shares of CG Oncology common stock.
01/31/2024Date of original Form 4 filing (subsequently amended).
04/09/2024Date of amended Form 4/A filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.